Does the mouse tail vein injection method provide a good model of lung cancer?

Lung cancer drug development requires screening in animal models. We aimed to develop orthotopic models of human non-small lung cancer using A549 and H3122 cells delivered by tail vein injection. This procedure has been used previously for a mouse lung cancer (Lewis lung carcinoma) and as a model of human breast cancer metastasis to lung. We report that the procedure led to poor animal condition 7-8 weeks after injection, and produced lesions in the lungs visible at necropsy but we were unable identify individual cancer cells using immunohistochemistry. We conclude that if this method is to produce a model that can be used in drug experiments, improvements are required for cancer cell detection post mortem, such as by using of a fluorescently tagged human lung cancer cell line.

[1]  Michael R. Green,et al.  Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis , 2017, Proceedings of the National Academy of Sciences.

[2]  Ahmedin Jemal,et al.  Global trends of lung cancer mortality and smoking prevalence. , 2015, Translational lung cancer research.

[3]  Francesco Petrella,et al.  Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.

[4]  Oliver Linsell,et al.  Cerebral hypoxia–ischemia causes cardiac damage in a rat model , 2014, Neuroreport.

[5]  B. Wilson,et al.  Orthotopic lung cancer murine model by nonoperative transbronchial approach. , 2014, The Annals of thoracic surgery.

[6]  J. Engelman,et al.  ALK in lung cancer: past, present, and future. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Milstien,et al.  Is tail vein injection a relevant breast cancer lung metastasis model? , 2013, Journal of thoracic disease.

[8]  liyan Huang,et al.  Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT. , 2012, Journal of thoracic disease.

[9]  Fang Liu,et al.  Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetent mice , 2012, Cell cycle.

[10]  H. Chew,et al.  The incidence of venous thromboembolism among patients with primary lung cancer , 2008, Journal of thrombosis and haemostasis : JTH.

[11]  JoAnn C L Schuh,et al.  Trials, Tribulations, and Trends in Tumor Modeling in Mice , 2004, Toxicologic pathology.